Absence of evidence of Borna disease virus infection in Swedish patients with chronic fatigue syndrome

Journal of NeuroVirology

Volumn 5, Issue 5, 1999, Pages 495-499

  Evengård, Birgitte ^a   Briese, Thomas ^b   Lindh, Gudrun ^a   Lee, Shaun ^b   Lipkin, W Ian ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Borna disease virus; CFS; PBMC; RT PCR; Serum

Indexed keywords

VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; BORNA DISEASE VIRUS; CHRONIC FATIGUE SYNDROME; COGNITIVE DEFECT; ENTEROVIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FATIGUE; FEMALE; GENETIC TRANSCRIPTION; HERPES VIRUS; HUMAN; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; RETROVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYMPTOM;

BORNA DISEASE VIRUS; ENTEROVIRUS; HERPES; HERPESVIRIDAE; UNIDENTIFIED RETROVIRUS;

EID: 0032864059     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.3109/13550289909045378     Document Type: Article

References (22)

1. Bennet AL, Chao CC, Hu S, Buchwald D, Fagioli LR, Schur PH, Peterspm PK, Komaroff AL (1997). Elevation of bioactive transforming growth factor-beta in serum from patients with chronic fatigue syndrome. J Clin Immunol 17: 160-166.
2. Bode L, Komaroff AL, Ludwig H (1992). No serologic evidence of Borna disease virus in patients with chronic fatigue syndrome. Clin Infect Dis 15: 1049.
3. Bode L, Zimmermann W, Ferszt R, Steinbach F, Ludwig H (1995). Borna disease virus genome transcribed and expressed in psychiatric patients. Nature Med 1: 232-236.
4. Briese T, Schneemann A, Lewis AJ, Park Y-S, Kim S, Ludwig H and Lipkin WL (1994). Genomic organization of Borna disease virus. Proc Natl Acad Sci USA 91: 4362-4366.
5. Briese T, Hatalski CG, Kliche S, Park Y, Lipkin WI (1995). Enzyme-linked immunosorbent assay for detecting antibodies to Borna Disease virus-specific proteins. J Clin Microbiol 33: 348-351.
6. Buchwald D, Ashley RL, Pearlman T, Kith P, Komaroff AL (1996). Viral serologies in patients with Chronic fatigue and Chronic fatigue syndrome. J Med Virol 50: 25-30.
7. Cannon JG, Angel JB, Abad LW, Vannier E, Mileno MD, Fagioli L, Wolff SM, Komaroff AL (1997). Interleukin-1 beta, interleukin-1 receptor antagonist, and soluble interleukin-1 receptor type II secretion in chronic fatigue syndrome. J Clin Immunol 17: 253-261.
8. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff AL (1994). The Chronic fatigue syndrome. A comprehensive approach to its definition and study. International chronic fatigue syndrome case definition study group. Ann Int Med 121: 953-959.
9. Gupta S, Aggarwal S, See D, Starr A (1997). Cytokine production by adherent and non-adherent mononuclear cells in chronic fatigue syndrome. J Psychiatr Res 31: 149-156.
10. Hatalski CG, Lewis AL, Lipkin WI (1997). Borna disease virus epidemiology and pathogenesis. Emerging Inf Dis 3: 129-135.
11. Jones JF, Ray CG, Minnich LL, Hicks MJ, Kibler R, Lucas DO (1985). Evidence of active Epstein-Barr virus infection in patients with persistent, unexplained illnesses: Elevated anti-early antigen antibodies. Ann Intern Med 102: 1-7.
12. Kishi M, Nakaya T, Nakamura Y, Zhong Q, Ikeda K, Senjo M, Kakinuma M, Kato S, Ikuta K (1995). Demonstration of human Borna disease virus RNA in human peripheral blood mononuclear cells. FEBS Lett 364: 293-297.
13. Kitani T, Kuratsune H, Fuke I, Nakamura Y, Nakaya T, Asahi S, Tobiume M, Yamaguti K, Macchii T, Inagi R, Yamanishi K, Ikuta K (1996). Possible cozrelation between Borna disease virus infection and Japanese patients with Chronic fatigue syndrome. Microbiol Immunol 40: 459-462.
14. Kliche S, Stitz L, Mangalam H, Shi L, Binz T, Niemann H, Briese T, Lipkin WI (1996). Characterization of the Borna disease virus phosphoprotein. p23. J Virol 70: 8133-8137.
15. Landay AL, Jessop C, Lennette ET, Levy JA (1991). Chronic fatigue syndrome: Clinical condition associated with immune activation. Lancet 338: 707-712.
16. Lundgren A-L, Czech G, Bode L, Ludwig H (1993). Natural Borna disease in domestic animals other than horses and sheep. J Vet Med 40: 298-303.
17. Nakaya T, Takahashi H, Nakamura Y, Asahi S, Tobiume M, Kuratsune H, Kitani T, Yamanishi K, Ikuta K (1996). Demonstration of Borna disease virus RNA in peripheral blood mononuclear cells derived from Japanese patients with Chronic fatigue syndrome. FEBS Letters 378: 145-149.
18. Salvatore M, Morzunov S, Schwemmle M, Lipkin WI and the Bornavirus Study Group (1997). Borna disease virus in brains of North American and European people with schizophrenia and bipolar disorder. Lancet 349: 1813-1814.
19. Sauder C, Mueller A, Cubitt B, Mayer J, Steinmetz J, Trabert W, Ziegler B, Wanke K, Mueller-Lantzsch N, de la Torre JC, Graesser F (1996). Detection of Borna disease virus (BDV) antibodies and BDV RNA in psychiatric patients: evidence for high sequence conservation of human blood-derivd BDV RNA. J Virol 70: 7713-7724.
20. Sauder C, de le Torre JC (1998). Sensitivity and reproducibility of RT-PCR to detect Borna disease virus (BDV) RNA in blood: implications for BDV epidemiology. J Virol Meth 71: 229-245.
21. Shimizu H, Shimizu C, Burns JC (1994). Detection of novel RNA viruses: morbilliviruses as a model system. Molecular Cellular Probes 8: 209-214.
22. Straus SE, Tosato G, Armstrong G, Lawley T, Preble O, Henle W, Davey R, Pearson G, Epstein J, Brus I, Blese RM (1985). Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection. Ann Intern Med 102: 7-16.